See more : Jacobs Engineering Group Inc. (0JOI.L) Income Statement Analysis – Financial Results
Complete financial analysis of Healthpeak Properties, Inc. (PEAK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Healthpeak Properties, Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
You may be interested
- Bank Handlowy w Warszawie S.A. (BHW.WA) Income Statement Analysis – Financial Results
- Storytel AB (publ) (STRYF) Income Statement Analysis – Financial Results
- Molecular Partners AG (MOLN.SW) Income Statement Analysis – Financial Results
- Grab Holdings Limited (GRABW) Income Statement Analysis – Financial Results
- AXMIN Inc. (AXMIF) Income Statement Analysis – Financial Results
Healthpeak Properties, Inc. (PEAK)
About Healthpeak Properties, Inc.
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.18B | 526.64M | 457.70M | 437.51M | 415.28M | 422.55M | 343.58M | 241.03M | 129.44M | 53.33M | 16.80M | 12.95M | 13.85M |
| Cost of Revenue | 902.66M | 171.10M | 137.41M | 128.20M | 124.82M | 122.62M | 97.04M | 66.00M | 31.03M | 10.15M | 4.65M | 4.76M | 4.95M |
| Gross Profit | 1.28B | 355.54M | 320.29M | 309.31M | 290.46M | 299.93M | 246.55M | 175.04M | 98.42M | 43.18M | 12.15M | 8.19M | 8.89M |
| Gross Profit Ratio | 58.61% | 67.51% | 69.98% | 70.70% | 69.94% | 70.98% | 71.76% | 72.62% | 76.03% | 80.96% | 72.32% | 63.25% | 64.23% |
| Research & Development | 0.00 | 0.25 | 0.07 | 0.13 | 0.14 | 0.57 | 0.22 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 95.13M | 40.21M | 37.76M | 33.76M | 33.10M | 28.82M | 22.96M | 18.40M | 14.91M | 11.44M | 3.69M | 1.31M | 1.25M |
| Selling & Marketing | 8.00M | 7.90M | 8.00M | 6.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 103.13M | 40.21M | 37.76M | 33.76M | 33.10M | 28.82M | 22.96M | 18.40M | 14.91M | 11.44M | 3.69M | 1.31M | 1.25M |
| Other Expenses | 0.00 | 189.64M | 157.87M | 149.59M | 146.44M | 158.39M | 125.16M | 86.59M | 45.47M | 16.73M | 5.11M | 4.15M | 4.59M |
| Operating Expenses | 103.13M | 229.85M | 195.63M | 183.35M | 179.54M | 187.21M | 148.12M | 104.99M | 60.38M | 28.17M | 8.80M | 5.46M | 5.84M |
| Cost & Expenses | 1.01B | 400.95M | 333.04M | 311.55M | 304.35M | 309.83M | 245.15M | 170.99M | 91.41M | 38.33M | 13.45M | 10.22M | 10.79M |
| Interest Income | 0.00 | 72.23M | 60.14M | 57.18M | 10.90M | 11.56M | 8.49M | 8.86M | 3.88M | 1.07M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 200.33M | 72.23M | 60.14M | 57.18M | 65.02M | 66.18M | 47.01M | 23.86M | 10.64M | 6.91M | 435.25M | 4.54M | 415.46M |
| Depreciation & Amortization | 749.90M | 1.71B | 1.58B | 1.47B | 951.11M | 1.41B | 1.46B | 1.41B | 45.47M | 16.73M | 5.11M | 4.43M | 4.78M |
| EBITDA | 1.19B | 314.54M | 280.96M | 1.13B | 257.34M | 989.69M | 926.97M | 1.29B | 1.13B | 1.16B | 1.71B | 1.51B | 1.25B |
| EBITDA Ratio | 54.54% | 59.73% | 61.39% | 62.69% | 61.97% | 64.19% | 65.13% | 65.03% | 64.59% | 59.69% | 60.44% | 55.27% | 69.32% |
| Operating Income | 1.18B | 124.90M | 123.09M | 124.70M | 110.90M | 112.73M | 98.43M | 70.05M | 38.04M | 15.01M | 1.41M | 1.56M | 1.62M |
| Operating Income Ratio | 53.88% | 23.72% | 26.89% | 28.50% | 26.70% | 26.68% | 28.65% | 29.06% | 29.38% | 28.14% | 8.41% | 12.07% | 11.68% |
| Total Other Income/Expenses | -860.27M | -585.65M | -894.39M | -533.07M | -130.62M | 121.75M | -148.23M | -905.82M | -1.07B | -882.22M | -423.23M | -432.06M | -542.92M |
| Income Before Tax | 314.94M | 110.04M | 86.78M | 68.49M | 77.19M | 58.32M | 39.77M | 31.52M | 12.74M | -4.42M | -2.64M | -2.85M | -3.33M |
| Income Before Tax Ratio | 14.44% | 20.89% | 18.96% | 15.65% | 18.59% | 13.80% | 11.58% | 13.08% | 9.84% | -8.28% | -15.69% | -22.04% | -24.01% |
| Income Tax Expense | -9.62M | 72.23M | 61.38M | 58.29M | 67.70M | 11.78M | 48.82M | 25.52M | 11.69M | 6.62M | 5.59M | 3.34M | 6.11M |
| Net Income | 306.01M | 37.80M | 25.40M | 10.20M | 9.49M | 56.23M | 38.15M | 29.98M | 11.79M | -4.04M | -2.24M | -1.66M | -3.06M |
| Net Income Ratio | 14.03% | 7.18% | 5.55% | 2.33% | 2.28% | 13.31% | 11.10% | 12.44% | 9.11% | -7.57% | -13.32% | -12.79% | -22.10% |
| EPS | 0.56 | 0.07 | 0.05 | 0.02 | 0.02 | 0.31 | 0.23 | 0.22 | 0.15 | -0.12 | -0.13 | -0.14 | -0.29 |
| EPS Diluted | 0.56 | 0.07 | 0.05 | 0.02 | 0.02 | 0.30 | 0.23 | 0.22 | 0.15 | -0.12 | -0.13 | -0.14 | -0.29 |
| Weighted Avg Shares Out | 547.01M | 538.81M | 538.93M | 204.24M | 185.77M | 470.55M | 163.12M | 138.51M | 79.88M | 36.30M | 14.15M | 11.73M | 11.73M |
| Weighted Avg Shares Out (Dil) | 547.28M | 539.15M | 539.24M | 211.15M | 191.63M | 475.39M | 168.23M | 143.25M | 84.32M | 36.30M | 14.15M | 11.73M | 11.73M |
Healthpeak Properties Enters into a New $236 Million Joint Venture with Breakthrough Properties on the Callan Ridge Lab Campus in Torrey Pines
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK) (“Healthpeak”), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced that it has formed a new strategic joint venture with Breakthrough Properties (“Breakthrough”) through a sale of...
Top 3 Real Estate Stock Picks for the New Year
Like broad markets, real estate stocks had a turbulent year in 2023. The first half of the year saw substantial downward pressure in both commercial and residential sectors due to interest rate hikes.
Healthpeak (PEAK) Gets Entitlements for Vantage Campus Development
Amid the robust demand for lab assets, Healthpeak (PEAK) receives entitlements for the development of an additional 1.3 million square feet of lab space at its Vantage Campus.
Healthpeak Properties Receives Entitlements for an Additional 1.3 Million Square Feet of Development at the Vantage Campus in South San Francisco
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK) (“Healthpeak”), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced it has received approval of entitlements for Phases II and III of its purpose-built lab development campus,...
Rewarding You: 7 REITs Yielding High Goldilocks-Zone Dividends
Identifying potentially habitable planets in the Goldilocks Zone is a primary focus in the search for extraterrestrial intelligence. Similarly, in dividend investing, there is a Goldilocks Zone where companies take just the right amount of risk with their dividend payouts....
Healthpeak Opportunistically Cheap As Supply Moderates
Healthpeak is undervalued and has the potential to trade at a higher multiple due to its high-quality characteristics. The decline in market price is primarily due to multiple contraction, not a decline in earnings power. The concentration of lab exposure...
Should Investors Hold Onto Healthpeak (PEAK) Stock for Now?
Healthpeak (PEAK) is poised to gain from the robust demand for lab assets and rising senior citizens' healthcare expenditure. However, competition from peers and high interest rates are woes.
Healthpeak (PEAK) Up 9.5% Since Last Earnings Report: Can It Continue?
Healthpeak (PEAK) reported earnings 30 days ago. What's next for the stock?
Rates Down, REITs Up
Rates down, REITs up? Two years of persistent rate-driven pressure on residential and commercial real estate markets appears to finally be abating as the worst of pandemic-era inflationary pressures subside. This 'light-at-the-end-of-the-tunnel' comes as commercial property values were approaching the...
Should You Buy the 5 Highest-Paying Dividend Stocks in the S&P 500?
The highest dividend yields in the S&P 500 range from 7.11% to 9.45%. A couple of these S&P 500 companies face challenges that should give investors pause.
Source: https://incomestatements.info
Category: Stock Reports